More than 2 million people in the United States live with hepatitis C. Many of them haven't been treated and are at risk for cirrhosis, liver failure, and other complications of the disease, even ...

The chronic viral inflammation of the liver that occurs in hepatitis C results in the formation of inflexible scar tissue in the form of fibrosis/cirrhosis of the liver. This impedes the flow of blood ...

Hepatitis C is a serious condition that can greatly affect your liver and overall health. The culprit is a virus called hepatitis C virus (HCV), which typically gets into a person’s system through ...

Use of direct-acting antiviral (DAA) treatment (without interferon) was shown to reduce liver and nonliver complications, as well as improve long-term overall survival among patients with chronic ...

The first prospective, longitudinal study investigating treatment of chronic hepatitis C with direct-acting antivirals finds that the treatment is associated with reduced risk of mortality and liver ...

HCV—can persist in the livers of those infected and even lead to liver disease or failure in extreme cases. It affects tens ...

Hepatitis C is a liver infection caused by the hepatitis C virus. It can be mild or serious. It can last just a few weeks or for a lifetime. Hepatitis C can cause both acute and chronic infections.

Hep C treatment challenges may include overcoming stigma, managing side effects, and coping with financial costs. But support is available. If you’ve received a hepatitis C diagnosis, it’s important ...

Untreated hepatitis C can lead to serious and life-threatening health problems like cirrhosis and liver cancer. Direct-acting antiviral therapies introduced in recent years are highly effective, with ...

New medications called direct-acting antivirals (DAAs) have transformed the treatment of hepatitis C. Twelve weeks on one of these drugs cures the infection in 95 percent or more of people who take it ...